// App-Quantinova.ai

P60.09 : Real-World Readiness of US Laboratories to Test Metastatic NSCLC Patients for Rare Actionable Genomic Variants by NGS

Researchers

Presenter

  • J. Sornkom

Principal Investigators

  • P. Cirillo

  • D. Keeling

  • J. Clark

Medical Centers

  • Diaceutics Plc, Belfast/GB

  • Diaceutics, Parsippany-Troy Hills/NJ/US

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

Biomarkers

  • TNF Receptor Superfamily Member 1A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved